Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Troy Media Scrub

<< Previous

Bullboard Posts

Next >>

Comment by Sailboatdreamon Apr 01, 2021 1:49pm

160 Views

Post# 32923914

RE:RE:RE:Troy Media Scrub

Going from unacceptable $0.27 to mediocre $1.49 does not reflect current value of company. Especially compared to peers. This is the elephant in the room... what will happen with the next release of great news? A temporary increase only to come back down the next week? These uncapitalized good news events are huge missed opportunities.

This is not mutiny. It is about identifying a pattern and recognizing that with current results valuation should be at least at par with peers. If current management and BoD do not know to translate clinical success and potential applications into market cap, questions about keeping them around are legitimate.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal